Gapping down
In reaction to disappointing earnings/guidance: RMBS -16.5%, HOG -8.6%, HXL -8.3%, VAR -5.7%, IBM -4.4%, IEX -2.2%, WIBC -1.4%, WWW -1.2%, ETN -1.1%, SIX -0.8%, ELS -0.6%, LMT -0.5%
M&A news: WDC -1.9% (Bloomberg reporting co is in discussion to acquire SNDK)
Select oil/gas related names showing early weakness: TOT -1.2%, BP -1%, RDS.A -0.8%
Other news: NEOS -13.7% (received notification that the FDA has identified deficiencies that preclude discussion of labeling & postmarketing requirements/commitments for Cotempla XR-ODT), ZGNX -7.4% (co received a request from the FDA for additional information related to the proposed Phase 3 program for ZX008 prior to the FDA declaring the Investigational New Drug Application effective), MSB -4.9% (reported that due to a delay in the reporting of Cliffs Natural Resources (CLF) regarding shipments of iron ore products, no distribution will be paid in November 2015), SGY -1.4% (filed mixed securities shelf offering), SNY -1.1% (may be in symp with AZN dg), AMD -1% (in symp with RMBS), ESI -0.9% (issues statement has received a letter from the U.S. Department of Education identifying certain past procedural deficiencies and requiring certain additional reporting, procedures and remedial actions)
Analyst comments: ENPH -7.2% (downgraded to Sell from Hold at Deutsche Bank), AZN -1.7% (downgraded to Underperform at Credit Suisse), VRX -2.2% (downgraded to Sector Perform from Sector Outperform at CIBC), CALM -1.1% (downgraded to Equal Weight from Overweight at a boutique firm), TS -0.8% (downgraded to Neutral from Buy at Citigroup), DO -0.8% (initiated with a Sell at Citigroup), PH -0.7% (downgraded to Neutral from Buy at Citigroup
)
In reaction to disappointing earnings/guidance: RMBS -16.5%, HOG -8.6%, HXL -8.3%, VAR -5.7%, IBM -4.4%, IEX -2.2%, WIBC -1.4%, WWW -1.2%, ETN -1.1%, SIX -0.8%, ELS -0.6%, LMT -0.5%
M&A news: WDC -1.9% (Bloomberg reporting co is in discussion to acquire SNDK)
Select oil/gas related names showing early weakness: TOT -1.2%, BP -1%, RDS.A -0.8%
Other news: NEOS -13.7% (received notification that the FDA has identified deficiencies that preclude discussion of labeling & postmarketing requirements/commitments for Cotempla XR-ODT), ZGNX -7.4% (co received a request from the FDA for additional information related to the proposed Phase 3 program for ZX008 prior to the FDA declaring the Investigational New Drug Application effective), MSB -4.9% (reported that due to a delay in the reporting of Cliffs Natural Resources (CLF) regarding shipments of iron ore products, no distribution will be paid in November 2015), SGY -1.4% (filed mixed securities shelf offering), SNY -1.1% (may be in symp with AZN dg), AMD -1% (in symp with RMBS), ESI -0.9% (issues statement has received a letter from the U.S. Department of Education identifying certain past procedural deficiencies and requiring certain additional reporting, procedures and remedial actions)
Analyst comments: ENPH -7.2% (downgraded to Sell from Hold at Deutsche Bank), AZN -1.7% (downgraded to Underperform at Credit Suisse), VRX -2.2% (downgraded to Sector Perform from Sector Outperform at CIBC), CALM -1.1% (downgraded to Equal Weight from Overweight at a boutique firm), TS -0.8% (downgraded to Neutral from Buy at Citigroup), DO -0.8% (initiated with a Sell at Citigroup), PH -0.7% (downgraded to Neutral from Buy at Citigroup
)